立方制药003020资产负债表 |
1814 ℃ |
当前股价:18.86,市值:36
亿,动态市盈率PE:20.73,
合理估值PE:15,未来三年预期收益率:44.72%。 其中,历史营业增长率:9.99%,净利增长率:19.97%; 未来三年预估净利增长率:10.78% (24E:-13.49%, 25E:25.11%, 26E:25.59%)。 |
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
货币资金(万) | 50292.9 | 64257.98 | 65425.4 | 76658.58 | 22324.41 | 15445.73 | 7642.99 | 7577.27 | - | 5725.38 |
交易性金融资产(万) | 6151.96 | 11.54 | 13.25 | - | - | - | - | - | - | - |
应收票据及应收账款(万) | 25923.93 | 32102.01 | 31817.07 | 26995.77 | 25854.84 | 22960.13 | 18128.39 | 10964.68 | - | - |
应收票据(万) | 79.2 | 9.9 | 3551.42 | 3489.87 | 2721.59 | 2354.6 | 3079.12 | 2884.58 | - | 583.58 |
应收账款(万) | 25844.73 | 32092.11 | 28265.65 | 23505.9 | 23133.25 | 20605.52 | 15049.27 | 8080.09 | - | 8070.8 |
应收款项融资(万) | 3594.66 | 3170.3 | 19.87 | 1532.56 | 647.59 | - | - | - | - | - |
预付款项(万) | 935.95 | 8107.44 | 5145.87 | 4133.09 | 2241.32 | 3441.34 | 1561.05 | 1945.57 | - | 1911.24 |
其他应收款(合计)(万) | 1997.35 | 432.99 | 608.13 | 307.27 | 282.53 | 1205.27 | 252.9 | 257.18 | - | - |
应收股利(万) | 495.65 | - | - | - | - | - | - | - | - | - |
其他应收款(万) | 1501.71 | 432.99 | 608.13 | 307.27 | - | - | - | - | - | 438.71 |
存货(万) | 24291.44 | 36176.49 | 18885.72 | 19379.99 | 17916.68 | 16882.73 | 15594.82 | 15490.85 | - | 14589.98 |
其他流动资产(万) | 1926.47 | 995.96 | 49.46 | 188.88 | 215.48 | 619.03 | 784.42 | 1264.27 | - | - |
流动资产合计(万) | 115114.66 | 145254.71 | 121964.77 | 129196.15 | 69482.86 | 60554.22 | 43964.58 | 37499.82 | - | 31319.68 |
可供出售金融资产(万) | - | - | - | - | - | - | 1800 | 1800 | - | 65 |
长期股权投资(万) | 16395.12 | 1439.8 | 2070.76 | - | - | - | - | - | - | - |
投资性房地产(万) | 2561.73 | 267.14 | 309.12 | 351.1 | 393.08 | 435.06 | 477.04 | 519.02 | - | 602.98 |
在建工程(合计)(万) | 45966.12 | 34089.25 | 13034.92 | 6646.53 | 3101.34 | 1140.25 | 357.3 | 12.84 | - | - |
在建工程(万) | 45966.12 | 34089.25 | 13034.92 | 6646.53 | - | - | - | - | - | 2743.14 |
固定资产及清理(合计)(万) | 42725.5 | 18237.64 | 14188.78 | 13256.77 | 11508.33 | 11847.45 | 11481.86 | 11929.58 | - | - |
固定资产净额(万) | 42725.5 | 18237.64 | 14188.78 | 13256.77 | - | - | - | - | - | 9508.01 |
生产性生物资产(万) | 240.34 | - | - | - | - | - | - | - | - | - |
使用权资产(万) | 930 | 1484.85 | 2679.24 | - | - | - | - | - | - | - |
无形资产(万) | 11328.51 | 8338.25 | 8950.81 | 3142.03 | 3150.96 | 2192.66 | 2125.53 | 2186.66 | - | 1943.54 |
开发支出(万) | 208.44 | 138.6 | 73.56 | - | - | - | - | - | - | 380 |
商誉(万) | 7444.05 | - | - | - | - | - | - | - | - | - |
长期待摊费用(万) | 532.47 | 622.84 | 805.94 | 89.8 | 49.22 | 45.72 | 52.3 | 55.29 | - | 106.99 |
递延所得税资产(万) | 1612.91 | 893.84 | 585.94 | 337.26 | 434.47 | 362.07 | 340.35 | 296.39 | - | 322 |
其他非流动资产(万) | 1664.19 | 1408.67 | 2780.64 | 582.32 | 861.04 | 523.26 | 686.19 | 480.59 | - | 572.75 |
非流动资产合计(万) | 133253.3 | 66920.88 | 45479.72 | 24405.82 | 19498.45 | 16546.47 | 17320.58 | 17280.38 | - | 16244.41 |
资产总计(万) | 248367.96 | 212175.59 | 167444.49 | 153601.96 | 88981.31 | 77100.7 | 61285.16 | 54780.2 | - | 47564.1 |
短期借款(万) | - | - | - | - | 2404.11 | 3500 | 6500 | 5000 | - | 7200 |
应付票据及应付账款(万) | 30125.05 | 46065.52 | 24292.88 | 28027.84 | 20034.86 | 17377.12 | 12779.93 | 15213.81 | - | - |
应付票据(万) | - | 21372.02 | 9367.67 | 16184.07 | 9764.76 | 8851.35 | 3345.37 | 3813.61 | - | 2952.17 |
应付账款(万) | 30125.05 | 24693.5 | 14925.2 | 11843.77 | 10270.1 | 8525.76 | 9434.56 | 11400.2 | - | 10734.63 |
预收款项(万) | 27.64 | - | - | - | 1648.52 | 1031.97 | 1346.52 | 1101.9 | - | 460.57 |
应付职工薪酬(万) | 3237.63 | 2628.15 | 2491.23 | 2088.39 | 1715.68 | 1266.39 | 1030.33 | 889.18 | - | 905.27 |
应交税费(万) | 3593.86 | 2768.4 | 2964.91 | 830.1 | 788.27 | 1098.93 | 890.53 | 786.44 | - | 1210.36 |
其他应付款(合计)(万) | 15641.3 | 4977.18 | 1410.3 | 1063.93 | 1550.38 | 907.14 | 600.18 | 672.92 | - | - |
应付股利(万) | 1568 | - | - | - | - | - | - | - | - | - |
其他应付款(万) | 14073.3 | 4977.18 | 1410.3 | 1063.93 | - | - | - | - | - | 1887.63 |
一年内到期的非流动负债(万) | 453.76 | 1003.27 | - | - | - | - | - | - | - | - |
其他流动负债(万) | 122.94 | 558.74 | 177.01 | 223.3 | - | - | - | - | - | 12 |
流动负债合计(万) | 54272.93 | 62262.82 | 32805.39 | 34234.84 | 28141.81 | 25181.54 | 23147.49 | 23664.25 | - | 25362.62 |
长期借款(万) | 3101.42 | - | - | - | - | - | - | - | - | - |
租赁负债(万) | 284.23 | 338 | 2458.36 | - | - | - | - | - | - | - |
长期应付款(合计)(万) | - | 116 | 465.98 | 729.98 | 467.98 | 465.98 | 1027.3 | 677.32 | - | - |
专项应付款(万) | - | 116 | 465.98 | 729.98 | - | - | - | - | - | 118.11 |
递延所得税负债(万) | 1343.22 | 138.75 | - | - | - | - | - | - | - | - |
长期递延收益(万) | 2016.36 | 1297.91 | 1323.69 | 1237.83 | 1371.75 | 883.12 | 939.03 | 629.23 | - | 530.02 |
非流动负债合计(万) | 6745.23 | 1890.66 | 4248.02 | 1967.81 | 1839.73 | 1349.1 | 1966.33 | 1306.55 | - | 648.13 |
负债合计(万) | 61018.16 | 64153.48 | 37053.42 | 36202.65 | 29981.54 | 26530.64 | 25113.82 | 24970.8 | - | 26010.75 |
实收资本(或股本)(万) | 15967.51 | 12246.7 | 9264 | 9264 | 6948 | 6948 | 6600 | 6600 | - | 6600 |
资本公积(万) | 55188.98 | 55493.29 | 52616.4 | 52215.35 | 6864.3 | 6864.3 | - | - | - | 638.07 |
减:库存股(万) | 2098.52 | 2704.52 | - | - | - | - | - | - | - | - |
盈余公积(万) | 8197.74 | 6337.34 | 4845.99 | 4809.49 | 3687.99 | 3680.1 | 2789.91 | 2223.55 | - | 1449.77 |
未分配利润(万) | 91296.92 | 76649.3 | 63664.69 | 51110.47 | 41499.48 | 33077.66 | 26781.43 | 20985.85 | - | 13224.59 |
归属于母公司股东权益合计(万) | 168552.63 | 148022.11 | 130391.08 | 117399.31 | 58999.77 | 50570.06 | 36171.35 | 29809.4 | - | 21912.44 |
少数股东权益(万) | 18797.17 | - | - | - | - | - | - | - | - | -359.09 |
所有者权益(或股东权益)合计(万) | 187349.8 | 148022.11 | 130391.08 | 117399.31 | 58999.77 | 50570.06 | 36171.35 | 29809.4 | - | 21553.35 |
负债和所有者权益(或股东权益)总计(万) | 248367.96 | 212175.59 | 167444.49 | 153601.96 | 88981.31 | 77100.7 | 61285.16 | 54780.2 | - | 47564.1 |